Georgy Sagaradze/LinkedIn
Oct 5, 2025, 05:53
Georgy Sagaradze: A Billion-Dollar In Vitro Fertilization Opportunity?
Georgy Sagaradze, Head of Precision Oncology Division at BostonGene, shared a post on LinkedIn:
“A billion-dollar in vitro fertilization opportunity: time to focus on the male factor?
Historically, male infertility has received less attention in the global infertility challenge. Yet with in vitro fertilization (IVF) achieving success in only about 30% of cases, the paradigm is shifting toward addressing male factors as well. Key drivers include:
- Growing social acceptance of assisted reproduction
- Expanding scientific evidence on the mechanisms of male infertility
- Clinical practice moving from female-centric to both-partner focus
- Rising VC investment in male infertility startups
Today this is a ~$1B niche. But with later maternal age and declining sperm quality worldwide, the opportunities ahead may be substantial.
What’s your view?
I’m ready to contribute and collaborate — who’s in?”

-
May 7, 2026, 16:23Amelia Degenkolb: ACOG 2026 Brings Innovation, Partnership and Patient Access Into Focus
-
May 7, 2026, 16:15New FIGO-IPPS Classification for Female Chronic Pelvic Pain – IJGO
-
May 7, 2026, 16:05Marco Zaccaria: How Uterine Fibroids Affect Latina Women
-
May 7, 2026, 12:36Adela Serban: Advanced Imaging Technique Enhances Uterine Imaging with 3D Ultrasound and Uterine Tracing
-
May 7, 2026, 12:26David Sable Highlights The Quest for Fertility as a Deep and Valuable Read
-
May 7, 2026, 12:20May Is Preeclampsia Awareness Month – The Society for Maternal-Fetal Medicine
-
May 7, 2026, 12:15PCOS Symptoms Should Not Be Dismissed – PCOS Awareness Association
-
May 7, 2026, 12:08Marco Zaccaria: The Role of the Junctional Zone in the Management of Adenomyosis With Infertility
-
May 7, 2026, 12:04Emad Sedeek: Understanding the Differences in PGT-A, PGT-M and PGT-P Embryogenetic Testing
